Skip to content
Advertisement

FILE - In this Jan. 30, 2019, file photo, Insys Therapeutics founder John Kapoor leaves federal court in Boston. Kapoor and former top employees of the pharmaceutical company are facing a reckoning for their role in a bribery scheme that prosecutors say boosted sales of a powerful, highly addictive painkiller and helped fuel the national opioid epidemic.Starting Monday, Jan. 13, 2020, seven people who worked for Insys Therapeutics will appear in Boston to be sentenced by a federal judge. (AP Photo/Steven Senne, File)

FILE - In this Jan. 30, 2019, file photo, Insys Therapeutics founder John Kapoor leaves federal court in Boston. Kapoor and former top employees of the pharmaceutical company are facing a reckoning for their role in a bribery scheme that prosecutors say boosted sales of a powerful, highly addictive painkiller and helped fuel the national opioid epidemic.Starting Monday, Jan. 13, 2020, seven people who worked for Insys Therapeutics will appear in Boston to be sentenced by a federal judge. (AP Photo/Steven Senne, File)

Featured Photo Galleries